7,577.50

+3.25

+0.04%

52,661.00

+163.00

+0.31%

27,921.50

-93.00

-0.33%

Russell 2000 Futures

2,850.00

+1.30

+0.05%

4.8640

+0.0050

+0.10%

20.14

+0.22

+1.10%

4,083.90

-30.60

-0.74%

74,275.48

-540.10

-0.72%

Crude Oil Dec 26

85.00

-1.85

-2.13%

US Private Equity

10,850.15

0.00

0.00%

NSE - Delayed Quote INR

Wockhardt Limited (WOCKPHARMA.NS)

2,031.50 +25.20 (+1.26%)

At close: November 9 at 3:30:02 PM GMT+5:30

Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight

GlobeNewswire 28d ago

WOCKPHARMA.NS
+1.26%
SPRO
Piyush Goyal and UK-India FTA Negotiation Teams Honoured at 10th Anniversary of IGF UK-India Awards

PR Newswire 4mo ago

WOCKPHARMA.NS
+1.26%

Mobilize your Website

View Site in Mobile | Classic

Share by: